TD Asset Management Inc. trimmed its holdings in Clorox Co (NYSE:CLX) by 0.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 279,176 shares of the company’s stock after selling 656 shares during the quarter. TD Asset Management Inc. owned 0.22% of Clorox worth $42,745,000 at the end of the most recent reporting period.
A number of other large investors have also bought and sold shares of the business. Tower View Investment Management & Research LLC raised its position in shares of Clorox by 19.4% during the 2nd quarter. Tower View Investment Management & Research LLC now owns 387 shares of the company’s stock worth $59,000 after purchasing an additional 63 shares during the last quarter. World Asset Management Inc raised its holdings in Clorox by 0.7% in the 2nd quarter. World Asset Management Inc now owns 9,872 shares of the company’s stock valued at $1,512,000 after acquiring an additional 65 shares during the last quarter. Berman Capital Advisors LLC raised its holdings in Clorox by 25.6% in the 1st quarter. Berman Capital Advisors LLC now owns 353 shares of the company’s stock valued at $56,000 after acquiring an additional 72 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. raised its holdings in Clorox by 9.7% in the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 849 shares of the company’s stock valued at $136,000 after acquiring an additional 75 shares during the last quarter. Finally, Merit Financial Group LLC raised its holdings in Clorox by 5.4% in the 1st quarter. Merit Financial Group LLC now owns 1,473 shares of the company’s stock valued at $236,000 after acquiring an additional 75 shares during the last quarter. 77.01% of the stock is currently owned by institutional investors.
Shares of Clorox stock traded up $2.41 during mid-day trading on Thursday, hitting $159.70. The stock had a trading volume of 10,751 shares, compared to its average volume of 1,072,105. The firm’s 50-day simple moving average is $158.44. Clorox Co has a 12-month low of $141.53 and a 12-month high of $167.70. The company has a current ratio of 0.91, a quick ratio of 0.55 and a debt-to-equity ratio of 4.09. The company has a market cap of $20.19 billion, a price-to-earnings ratio of 25.11, a P/E/G ratio of 4.98 and a beta of 0.37.
The company also recently declared a quarterly dividend, which will be paid on Friday, August 16th. Stockholders of record on Wednesday, July 31st will be paid a $1.06 dividend. This is a boost from Clorox’s previous quarterly dividend of $0.96. The ex-dividend date is Tuesday, July 30th. This represents a $4.24 annualized dividend and a dividend yield of 2.65%. Clorox’s dividend payout ratio is 67.09%.
A number of analysts have commented on CLX shares. Morgan Stanley increased their price objective on shares of Clorox from $141.00 to $144.00 and gave the company an “underweight” rating in a report on Friday, August 2nd. BMO Capital Markets set a $168.00 price objective on shares of Clorox and gave the company a “buy” rating in a report on Thursday, May 2nd. Zacks Investment Research upgraded shares of Clorox from a “sell” rating to a “hold” rating and set a $175.00 price objective for the company in a report on Monday, July 29th. ValuEngine downgraded shares of Clorox from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Finally, Deutsche Bank upgraded shares of Clorox from a “sell” rating to a “hold” rating and set a $139.00 price objective for the company in a report on Thursday, May 2nd. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company. Clorox presently has a consensus rating of “Hold” and an average target price of $154.07.
In related news, Director A D. David Mackay sold 3,400 shares of the stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $154.87, for a total transaction of $526,558.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Diego J. Barral sold 1,987 shares of the stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $157.59, for a total transaction of $313,131.33. The disclosure for this sale can be found here. In the last three months, insiders sold 25,786 shares of company stock valued at $4,054,776. Corporate insiders own 1.40% of the company’s stock.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Story: Strike Price
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.